BR9703161A - Cromanos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos - Google Patents

Cromanos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos

Info

Publication number
BR9703161A
BR9703161A BR9703161A BR9703161A BR9703161A BR 9703161 A BR9703161 A BR 9703161A BR 9703161 A BR9703161 A BR 9703161A BR 9703161 A BR9703161 A BR 9703161A BR 9703161 A BR9703161 A BR 9703161A
Authority
BR
Brazil
Prior art keywords
medicine
chromans
sulfonamide
diagnosis
replaced
Prior art date
Application number
BR9703161A
Other languages
English (en)
Portuguese (pt)
Inventor
Heinz Goegelein
Heinrich Christian Englert
Joachim Brendel
Helmut Bohn
Andreas Herling
Hans Jochen Lang
Andreas Busch
Uwe Gerlach
Rainer Greger
Max Hropot
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19619614A external-priority patent/DE19619614A1/de
Priority claimed from DE1996139462 external-priority patent/DE19639462A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of BR9703161A publication Critical patent/BR9703161A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/68—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with nitrogen atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BR9703161A 1996-05-15 1997-05-14 Cromanos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos BR9703161A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19619614A DE19619614A1 (de) 1996-05-15 1996-05-15 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE1996139462 DE19639462A1 (de) 1996-09-26 1996-09-26 Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Publications (1)

Publication Number Publication Date
BR9703161A true BR9703161A (pt) 1998-09-29

Family

ID=26025736

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9703161A BR9703161A (pt) 1996-05-15 1997-05-14 Cromanos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos

Country Status (23)

Country Link
EP (1) EP0807629B1 (enExample)
JP (1) JP4234798B2 (enExample)
KR (1) KR100547921B1 (enExample)
CN (1) CN1204134C (enExample)
AR (2) AR007115A1 (enExample)
AT (1) ATE260909T1 (enExample)
AU (1) AU711986B2 (enExample)
BR (1) BR9703161A (enExample)
CA (1) CA2205477A1 (enExample)
CZ (1) CZ149497A3 (enExample)
DE (1) DE59711352D1 (enExample)
DK (1) DK0807629T3 (enExample)
ES (1) ES2218617T3 (enExample)
HR (1) HRP970255B1 (enExample)
HU (1) HUP9700903A3 (enExample)
IL (1) IL120827A (enExample)
NO (1) NO315556B1 (enExample)
NZ (1) NZ314800A (enExample)
PL (1) PL191330B1 (enExample)
PT (1) PT807629E (enExample)
SK (1) SK283837B6 (enExample)
TR (1) TR199700369A2 (enExample)
TW (1) TW496866B (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ329200A (en) * 1996-12-16 1999-05-28 Hoechst Ag Sulphonamide substituted quinazoline, isoquinoline, quinoline or benzo[1,3-]oxazine derivatives and medicaments
DE19705133A1 (de) * 1997-02-11 1998-08-13 Hoechst Ag Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19706675A1 (de) * 1997-02-20 1998-08-27 Hoechst Ag Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
EP0895994A3 (de) 1997-08-05 1999-12-15 Hoechst Marion Roussel Deutschland GmbH Sulfonamid-substituierte Pyranopyridine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE19742508A1 (de) 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19742509A1 (de) * 1997-09-26 1999-04-01 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
DE19748469A1 (de) * 1997-11-03 1999-05-06 Hoechst Marion Roussel De Gmbh Sulfonamid-substituierte Benzopyranderivate, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
AU754204B2 (en) 1998-09-01 2002-11-07 Bristol-Myers Squibb Company Potassium channel inhibitors and method
DE19858253A1 (de) * 1998-12-17 2000-06-21 Aventis Pharma Gmbh Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
US7368582B2 (en) 2003-10-17 2008-05-06 Solvay Pharmaceuticals Gmbh Amidomethyl-substituted 2-(4-sulfonylamino)-3-hydroxy-3,4-dihydro-2H-chromen-6-yl compounds, a process and intermediates for their production, and pharmaceutical compositions containing them
WO2005090357A1 (en) * 2004-03-23 2005-09-29 Nissan Chemical Industries, Ltd. Tricyclic benzopyran compound as anti-arrhythmic agents
US7884109B2 (en) 2005-04-05 2011-02-08 Wyeth Llc Purine and imidazopyridine derivatives for immunosuppression
US7989459B2 (en) 2006-02-17 2011-08-02 Pharmacopeia, Llc Purinones and 1H-imidazopyridinones as PKC-theta inhibitors
WO2008043031A1 (en) 2006-10-04 2008-04-10 Pharmacopeia, Inc. 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
AR063141A1 (es) 2006-10-04 2008-12-30 Pharmacopeia Inc Derivados de 2- ( benzimidazolil ) purina 8- sustituida para inmunosupresion
US7902187B2 (en) 2006-10-04 2011-03-08 Wyeth Llc 6-substituted 2-(benzimidazolyl)purine and purinone derivatives for immunosuppression
EP2426133B1 (en) * 2009-04-30 2015-12-16 Nissan Chemical Industries, Ltd. Novel crystal forms of tricyclic benzopyran compound and processes for producing same
TWI583677B (zh) * 2012-09-21 2017-05-21 日本臟器製藥股份有限公司 香豆素衍生物
CN103012380B (zh) * 2013-01-10 2015-03-04 山东大学 一种色满类化合物及其制备方法与应用
JP6089055B2 (ja) * 2014-03-20 2017-03-01 日本臓器製薬株式会社 クマリン誘導体を含有する医薬
AR117169A1 (es) 2018-11-28 2021-07-14 Bayer Ag (tio)amidas de piridazina como compuestos fungicidas
BR112022022595A2 (pt) 2020-05-06 2022-12-20 Bayer Ag Piridina (tio)amidas como compostos fungicidas
CN115605462A (zh) 2020-05-12 2023-01-13 拜耳公司（De） 作为杀真菌化合物的三嗪和嘧啶(硫代)酰胺
CN115803317B (zh) 2020-05-19 2025-07-15 拜耳作物科学股份公司 作为杀真菌化合物的氮杂双环(硫代)酰胺
WO2021239766A1 (en) 2020-05-27 2021-12-02 Bayer Aktiengesellschaft Active compound combinations
CN118541353A (zh) 2021-11-03 2024-08-23 拜耳公司 作为杀真菌化合物的双(杂)芳基硫醚(硫代)酰胺

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3737195A1 (de) * 1987-11-03 1989-05-18 Bayer Ag Chromanderivate, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
FR2639349B1 (fr) * 1988-11-23 1991-02-22 Sanofi Sa Nouveaux derives du chromane actifs sur le systeme nerveux central, leur procede de preparation et les compositions pharmaceutiques en contenant
US5104890A (en) * 1989-03-28 1992-04-14 Fujisawa Pharmaceutical Company, Ltd. Benzopyran derivatives and processes for preparation thereof

Also Published As

Publication number Publication date
IL120827A (en) 2004-12-15
NO315556B1 (no) 2003-09-22
PL319995A1 (en) 1997-11-24
SK283837B6 (sk) 2004-03-02
ES2218617T3 (es) 2004-11-16
HK1006640A1 (en) 1999-03-12
CA2205477A1 (en) 1997-11-15
CN1169429A (zh) 1998-01-07
TR199700369A2 (xx) 1997-12-21
HRP970255B1 (en) 2003-10-31
MX9703534A (es) 1997-11-29
DE59711352D1 (de) 2004-04-08
PL191330B1 (pl) 2006-04-28
NO972211L (no) 1997-11-17
AR007115A1 (es) 1999-10-13
EP0807629B1 (de) 2004-03-03
ATE260909T1 (de) 2004-03-15
PT807629E (pt) 2004-07-30
EP0807629A1 (de) 1997-11-19
JP4234798B2 (ja) 2009-03-04
TW496866B (en) 2002-08-01
KR100547921B1 (ko) 2006-10-19
KR19980024020A (ko) 1998-07-06
CZ149497A3 (en) 1997-12-17
HRP970255A2 (en) 1998-04-30
NZ314800A (en) 1999-02-25
HU9700903D0 (en) 1997-07-28
SK60397A3 (en) 1998-02-04
AU711986B2 (en) 1999-10-28
NO972211D0 (no) 1997-05-14
HUP9700903A3 (en) 1999-03-01
AU2080697A (en) 1997-11-20
CN1204134C (zh) 2005-06-01
DK0807629T3 (da) 2004-05-17
HUP9700903A2 (hu) 1998-12-28
IL120827A0 (en) 1997-09-30
JPH1067772A (ja) 1998-03-10
AR010314A1 (es) 2000-06-07

Similar Documents

Publication Publication Date Title
BR9703161A (pt) Cromanos substituídos por sulfonamida processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo os mesmos
BR9605417A (pt) Sulfonimidamidas substituídas processos para a sua preparação seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
BR8008278A (pt) Instrumento de medicao de espessura de tecidos, para propositos cirurgicos
DE69018380D1 (de) Verbesserungen für Blutentnahmegeräte.
BR9807843B1 (pt) heterociclos bicìclicos dissubstituìdos, composições farmacêuticas, uso, bem como processos para preparação das referidas composições e dos referidos compostos.
BR9807685B1 (pt) ftalazinas, preparaÇço farmacÊutica que as compreende, bem como uso das mesmas.
DK647087A (da) Substituerede basiske tetraliner, fremgangsmaade til deres fremstilling samt deres anvendelse som laegemidler
BR9911123B1 (pt) compostos derivados de diàxido de benzotiepina-1,1, processo para sua preparaÇço e seu uso, medicamentos contendo-os e processo para a preparaÇço desses.
DK87187A (da) Cycloalkanooe1,2-baaindolsulfonamider, isomere og salte deraf, deres fremstilling og anvendelse som laegemiddel samt fremstillingsmellemprodukter
BR0015254B1 (pt) compostos derivados de carbamoiloxialquil-azàlio, seu uso, bem como composiÇço farmacÊutica compreendendo os mesmos.
NO972433L (no) Substituerte 2-naftoylguanidiner, fremgangsmåter for deres fremstilling, deres anvendelse som medikament eller diagnostikum samt medikamenter inneholdende forbindelsene
DK0723956T3 (da) Basisk substituerede benzoylguanidiner, fremgangsmåde til fremstilling deraf, anvendelse deraf som lægemiddel eller diagnos
BR9703440A (pt) Benzoilguadinas orto-substituídas processos para sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas
BR9800708A (pt) Cromans substituídos com sulfonamida processos para a sua preparação sua utilização como medicamento ou auxiliares de diagnóstico e medicamento compreendendo os mesmos
NO962006L (no) Substituerte benzyloksykarbonylguanidiner, fremgangsmåte for deres fremstilling, deres anvendelse som medikament eller diagnostikum såvel som legemiddel inneholdende dem
NO952596D0 (no) Orto-aminosubstituerte benzoylguandiner, fremgangsmåter for deres fremstilling, deres anvendelse som legemiddel eller diagnostikum såvel som medikamenter som inneholder dem
NO904576D0 (no) Aminopyridinylaminofenol og beslektede forbindelser, mellomprodukter, fremgangsmaate for deres fremstilling og anvendelse som medikamenter.
FI894650L (fi) Antigen, som associerar till en human tumoer.
PT915087E (pt) Compostos anelados de cinco aneis, susbtituidos por sulfonamida, sua utilizacao como medicamentos, bem como preparacoes farmaceuticas contendo os mesmos
BR9705509B1 (pt) derivados de 4-hidràxi-piperidina, processo para a preparaÇço dos mesmos, bem como medicamento contendo os mesmos.
BR9800596A (pt) Compostos sulfonamida substituídos processos para sua preparação seus usos como medicamento ou diagnostico e um medicamento compreendendo os mesmos
BR8901036A (pt) Compostos,processo para sua preparacao,bem como sua aplicacao
BR9703617A (pt) Benzoilguanidinas orto-substituídas processo para a sua preparação seu emprego como medicamento ou diagnóstico bem como medicamento contendo as mesmas
BR9605568A (pt) Benzoilguanidinas substituídas por sulfonilamino processo para a sua preparaçao seu emprego como medicamento ou diagnóstico bem como o medicamento contendo as mesmas
DE69014756D1 (de) Herbizide Sulfonamide.

Legal Events

Date Code Title Description
FB34 Technical and formal requirements: requirement - article 34 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements